Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Ovarian”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01549925
What this trial is testing

Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand

Who this might be right for
Epithelial Ovarian Cancer
University of Utah 50
Testing effectiveness (Phase 2)Study completedNCT00479817
What this trial is testing

Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Amgen 161
Not applicableStudy completedNCT04460768
What this trial is testing

An INternational Frontline Ovarian Cancer Real World Management Study

Who this might be right for
Ovarian Neoplasms
AstraZeneca 989
Early research (Phase 1)Study completedNCT02159989
What this trial is testing

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 83
Testing effectiveness (Phase 2)Study completedNCT01824615
What this trial is testing

Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma

Who this might be right for
Ovarian CancerAdverse Effects
Cathay General Hospital 30
Early research (Phase 1)Study completedNCT02526017
What this trial is testing

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

Who this might be right for
Advanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more
Five Prime Therapeutics, Inc. 313
Testing effectiveness (Phase 2)Study completedNCT00002474
What this trial is testing

Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Loyola University
Testing effectiveness (Phase 2)Study completedNCT00937560
What this trial is testing

First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hoffmann-La Roche 190
Large-scale testing (Phase 3)UnknownNCT06211023
What this trial is testing

SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 520
Early research (Phase 1)Looking for participantsNCT05172310
What this trial is testing

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Who this might be right for
Pancreatic NeoplasmsStomach NeoplasmsBile Duct Neoplasms+1 more
Karolinska University Hospital 410
Not applicableUnknownNCT03150121
What this trial is testing

Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage

Who this might be right for
Ovarian CancerOvarian CarcinomaFallopian Tube Cancer+2 more
Sheba Medical Center 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07117877
What this trial is testing

Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer

Who this might be right for
Platinum Resistant Ovarian CancerPlatinum Refractory Epithelial Ovarian CancerOvarian Cancer (OvCa)
Fudan University 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07489300
What this trial is testing

Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Early research (Phase 1)UnknownNCT01456065
What this trial is testing

Safety of Active Immunotherapy in Subjects With Ovarian Cancer

Who this might be right for
Ovarian Epithelial Cancer
Life Research Technologies GmbH 15
Not applicableUnknownNCT05576519
What this trial is testing

Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian Carcinoma

Who this might be right for
Ovarian Carcinoma
Sohag University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06690775
What this trial is testing

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Who this might be right for
Epithelial Ovarian CancerPrimary PeritonealFallopian Tube Cancer+1 more
TORL Biotherapeutics, LLC 230
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07811297
What this trial is testing

Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers

Who this might be right for
Endometrial NeoplasmsOvarian NeoplasmsSoft Tissue Sarcoma (STS)+1 more
Advenchen Pharmaceuticals, LLC. 138
Testing effectiveness (Phase 2)UnknownNCT02132988
What this trial is testing

Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer

Who this might be right for
Ovarian Cancer
Mackay Memorial Hospital 110
Not applicableActive Not RecruitingNCT01276574
What this trial is testing

Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Turku University Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00861120
What this trial is testing

Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type

Who this might be right for
Epithelial Ovarian Cancer
Vejle Hospital 33
Next Page